Black Swift Group LLC Boosts Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Black Swift Group LLC grew its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 98.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,300 shares of the company’s stock after purchasing an additional 7,100 shares during the quarter. Black Swift Group LLC owned 0.05% of Establishment Labs worth $659,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in ESTA. Kornitzer Capital Management Inc. KS boosted its stake in shares of Establishment Labs by 2.5% in the third quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company’s stock valued at $10,750,000 after purchasing an additional 6,050 shares during the period. Simplify Asset Management Inc. boosted its stake in shares of Establishment Labs by 67.7% in the third quarter. Simplify Asset Management Inc. now owns 21,639 shares of the company’s stock valued at $936,000 after purchasing an additional 8,732 shares during the period. Mudita Advisors LLP raised its holdings in Establishment Labs by 19.0% in the third quarter. Mudita Advisors LLP now owns 354,801 shares of the company’s stock valued at $15,352,000 after acquiring an additional 56,700 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Establishment Labs by 1.8% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock valued at $1,525,000 after acquiring an additional 632 shares in the last quarter. Finally, Stonepine Capital Management LLC acquired a new stake in Establishment Labs in the third quarter valued at approximately $3,245,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Down 5.6 %

Shares of NASDAQ:ESTA opened at $43.60 on Thursday. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a fifty-two week low of $28.16 and a fifty-two week high of $60.12. The firm’s 50 day moving average price is $37.55 and its 200 day moving average price is $41.37. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -16.90 and a beta of 0.95.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. As a group, equities research analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Stephens reaffirmed an “overweight” rating and issued a $52.00 target price on shares of Establishment Labs in a report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Establishment Labs currently has an average rating of “Moderate Buy” and a consensus target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.